AVORO CAPITAL ADVISORS LLC 13D and 13G filings for Relmada Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 10:08 am Sale | 2021-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | AVORO CAPITAL ADVISORS LLC | 0 0.000% | -1,525,000 (Position Closed) | Filing |
| 2021-02-12 08:05 am Purchase | 2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | AVORO CAPITAL ADVISORS LLC | 1,525,000 9.400% | 1,525,000 (New Position) | Filing |